Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 31, Issue 1, 2004, Pages 51-54

  Nakamori, Shoji ^a   Tujie, Masanori ^a   Takahashi, Yuji ^a   Maruhashi, Shigeru ^a   Miyamoto, Atsushi ^a   Nagano, Hiroaki ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Sakon, Masato ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; TEGAFUR; UFT(R) DRUG; URACIL;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; LEUKOPENIA; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEUTROPENIA; PANCREAS TUMOR; PHASE 1 CLINICAL TRIAL; TUMOR RECURRENCE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; LEUKOPENIA; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; PANCREATIC NEOPLASMS; TEGAFUR; URACIL;

EID: 1342267492     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)